Literature DB >> 10681212

Obtaining unacceptable results in assays for quantitation of human immunodeficiency virus type 1 RNA in plasma samples.

A Aguilera, A Vela, M Treviño, E Varela, R Seoane, B J Regueiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10681212      PMCID： PMC88760          DOI： 10.1128/JCM.38.1.472-473.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  18 in total

1.  Inaccurate HIV-1 viral load quantification by three major commercially available methods.

Authors:  R B Oelrichs; W B Dyer; J C Downie; K Harvey; J S Sullivan; C Workman
Journal:  AIDS       Date:  1999-04-16       Impact factor: 4.177

2.  Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays.

Authors:  C C Ginocchio; S Tetali; D Washburn; F Zhang; M H Kaplan
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

Review 3.  The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs.

Authors:  J S Murray; M R Elashoff; L C Iacono-Connors; T A Cvetkovich; K A Struble
Journal:  AIDS       Date:  1999-05-07       Impact factor: 4.177

Review 4.  Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

Authors:  J Lew; P Reichelderfer; M Fowler; J Bremer; R Carrol; S Cassol; D Chernoff; R Coombs; M Cronin; R Dickover; S Fiscus; S Herman; B Jackson; J Kornegay; A Kovacs; K McIntosh; W Meyer; N Michael; L Mofenson; J Moye; T Quinn; M Robb; M Vahey; B Weiser; T Yeghiazarian
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

5.  Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma.

Authors:  J R Dyer; C D Pilcher; R Shepard; J Schock; J J Eron; S A Fiscus
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

6.  Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification.

Authors:  B van Gemen; T Kievits; P Nara; H G Huisman; S Jurriaans; J Goudsmit; P Lens
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

7.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

8.  Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  C C Ginocchio; X P Wang; M H Kaplan; G Mulligan; D Witt; J W Romano; M Cronin; R Carroll
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

9.  Comparison of the Amplicor HIV-1 monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles.

Authors:  B P Griffith; M O Rigsby; R B Garner; M M Gordon; T M Chacko
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

10.  Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  H J Lin; L Pedneault; F B Hollinger
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.